Suchergebnisse - (Person:"Liu, Binliang")

PubPharm (44)

11

Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer

enthalten in: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu | 2022

von Lyu, D. | Liu, B. | Lan, B. | +5

12

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients

enthalten in: Cancer medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

13

Clinical and genetic predictions of early-onset cardiac toxicity in adjuvant chemotherapy for breast cancer

enthalten in: Future oncology (London, England) | 2022

von Liu, B. | Guan, X. | Wang, Y. | +8

14

Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC

enthalten in: Frontiers in endocrinology | 2022

von Tang, Y. | Li, J. | Liu, B. | +3

15

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients

enthalten in: Cancer Medicine | 2022

von Liu, B. | Yi, Z. | Guan, Y. | +10

16

Antibody-drug conjugates in HER2-positive breast cancer

enthalten in: Chinese medical journal | 2021

von Li, L. | Zhang, D. | Liu, B. | +5

17

The molecular tumor burden index as a response evaluation criterion in breast cancer

enthalten in: Signal transduction and targeted therapy | 2021

von Yi, Z. | Ma, F. | Rong, G. | +10

18

Knowledge level of cardio-oncology in oncologist and cardiologist: A survey study in China

enthalten in: ResearchSquare.com | 2021

von Liu, B. | Wang, Y. | An, T. | +8

19

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer

enthalten in: Frontiers in oncology | 2021

von Guan, X. | Li, C. | Li, Y. | +8

20

Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China

enthalten in: Journal of cancer research and clinical oncology | 2020

von Mo, H. | Liu, B. | Ma, F.